Eyestem Research Pvt Ltd announced the completion of its phase one study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The clinical study report of the study has been submitted to the Central Drugs Standard Control Organisation (CDSCO) for permission to start the phase 2 study. The
LV Prasad Eye Institute and Fernandez Foundation cohosted the eighth Equitable Healthcare Access Consortium (EHAC) Member’s meeting from 6 to 7 December at the LVPEI’s campus in the city. The consortium’s agenda includes promoting discussion and action to deliver equitable healthcare by addressing challenges such
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
